title: Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
authors.affiliation: University of California San Francisco, San Francisco, CA 94143, USA.
authors.forename: Renee
authors.initials: R
authors.lastname: Modica
authors.forename: Helen
authors.initials: H
authors.lastname: Emery
authors.forename: Wilbur
authors.initials: W
authors.lastname: Lam
authors.forename: Michelle
authors.initials: M
authors.lastname: Hermiston
authors.forename: James
authors.initials: J
authors.lastname: Grenert
authors.forename: Michael
authors.initials: M
authors.lastname: Wirt
authors.forename: Emily
authors.initials: E
authors.lastname: von Scheven
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000473:pathology / Q000821:virology*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000473:pathology; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007249:Inflammation / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000473:pathology / Q000821:virology*; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D016572:Cyclosporine